These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30524061)

  • 1. Design and testing of a microcontroller that enables alpha particle irradiators to deliver complex dose rate patterns.
    Nawrocki T; Tritt TC; Neti PVSV; Rosen AS; Dondapati AR; Howell RW
    Phys Med Biol; 2018 Dec; 63(24):245022. PubMed ID: 30524061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetry and radiobiological studies of automated alpha-particle irradiator.
    M V JB; Shinde SG; S SK; Ali M; Vasumathy R; Kumar A; Kolekar R; Kumar M; Nema P; Bhagwat PV; Pandey BN
    J Environ Pathol Toxicol Oncol; 2013; 32(3):263-73. PubMed ID: 24266413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.
    Sgouros G; Hobbs R; Josefsson A
    Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-port low-fluence alpha-particle irradiator: fabrication, testing and benchmark radiobiological studies.
    Neti PV; de Toledo SM; Perumal V; Azzam EI; Howell RW
    Radiat Res; 2004 Jun; 161(6):732-8. PubMed ID: 15161346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRACKING DOWN ALPHA-PARTICLES: THE DESIGN, CHARACTERISATION AND TESTING OF A SHALLOW-ANGLED ALPHA-PARTICLE IRRADIATOR.
    Thompson JM; Elliott A; D'Abrantes S; Sawakuchi GO; Hill MA
    Radiat Prot Dosimetry; 2019 May; 183(1-2):264-269. PubMed ID: 30726978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Lee D; Li M; Bednarz B; Schultz MK
    Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIRD Pamphlet No. 22 (abridged): radiobiology and dosimetry of alpha-particle emitters for targeted radionuclide therapy.
    Sgouros G; Roeske JC; McDevitt MR; Palm S; Allen BJ; Fisher DR; Brill AB; Song H; Howell RW; Akabani G; ; Bolch WE; Brill AB; Fisher DR; Howell RW; Meredith RF; Sgouros G; Wessels BW; Zanzonico PB
    J Nucl Med; 2010 Feb; 51(2):311-28. PubMed ID: 20080889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
    Aghevlian S; Boyle AJ; Reilly RM
    Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining relative biological effectiveness in the context of the EQDX formalism: implications for alpha-particle emitter therapy.
    Hobbs RF; Howell RW; Song H; Baechler S; Sgouros G
    Radiat Res; 2014 Jan; 181(1):90-8. PubMed ID: 24502376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Effect of Chelating Arms and Carrier Agents on t he Radiotoxicity of TAT Agents.
    Farzipour S; Shaghaghi Z; Raeispour M; Alvandi M; Jalali F; Yazdi A
    Curr Radiopharm; 2023; 16(1):2-22. PubMed ID: 35538822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A versatile plutonium-238 irradiator for radiobiological studies with alpha-particles.
    Goodhead DT; Bance DA; Stretch A; Wilkinson RE
    Int J Radiat Biol; 1991 Jan; 59(1):195-210. PubMed ID: 1671067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cell irradiation systems based on 210Po alpha source: construction and characterisation.
    Szabo J; Feher I; Palfalvi J; Balashazy I; Dam AM; Polonyi I; Bogdandi EN
    Radiat Meas; 2002 Dec; 35(6):575-8. PubMed ID: 12455514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Targeted Alpha Particle Therapy for Solid Tumors.
    Tafreshi NK; Doligalski ML; Tichacek CJ; Pandya DN; Budzevich MM; El-Haddad G; Khushalani NI; Moros EG; McLaughlin ML; Wadas TJ; Morse DL
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.
    Huclier-Markai S; Alliot C; Varmenot N; Cutler CS; Barbet J
    Curr Top Med Chem; 2012; 12(23):2642-54. PubMed ID: 23339760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
    Lindegren S; Frost SH
    Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-particle microdosimetry.
    Chouin N; Bardies M
    Curr Radiopharm; 2011 Jul; 4(3):266-80. PubMed ID: 22201713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alpha-radioimmunotherapy: a review of recent developments].
    Supiot S; Thillays F; Rio E; Mahé MA; Barbet FJ; Kraeber-Bodéré F; Chérel M
    Cancer Radiother; 2007 Sep; 11(5):252-9. PubMed ID: 17604673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery.
    Coll RP; Bright SJ; Martinus DKJ; Georgiou DK; Sawakuchi GO; Manning HC
    Mol Imaging Biol; 2023 Dec; 25(6):991-1019. PubMed ID: 37845582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.